Verma P S, Gagnon J A, Miller R L
Department of Medicine, College of Medicine, Howard University, Washington, D.C.
Ren Physiol. 1988;10(6):311-7. doi: 10.1159/000173140.
The intrarenal kallikrein-kinin system was studied during the acute phase of renovascular hypertension induced by renal artery constriction and during teprotide inhibition of kininase II in the dog. Kallikrein-like activity measured by both kininogenase and esterolytic assays, was increased during renal artery constriction (p less than 0.5) and (p less than 0.01). The administration of teprotide resulted in a further increase of renal cortical kallikrein-like activity and inhibited kininase II activity (p less than 0.01). Following the inhibition of kininase II, the plasma concentration of kininogen was also significantly decreased (p less than 0.01). These results suggest that kininase II inhibition may increase levels of intrarenal and plasma kinins and that decreased degradation of kinin peptides may contribute significantly to the acute hypertensive effect of teprotide.
在犬肾动脉狭窄诱导的肾血管性高血压急性期以及抑肽酶抑制激肽酶II期间,对肾内激肽释放酶-激肽系统进行了研究。通过激肽原酶和酯解测定法测得的类激肽释放酶活性在肾动脉狭窄期间增加(p < 0.5)以及(p < 0.01)。给予抑肽酶导致肾皮质类激肽释放酶活性进一步增加并抑制激肽酶II活性(p < 0.01)。在抑制激肽酶II后,激肽原的血浆浓度也显著降低(p < 0.01)。这些结果表明,抑制激肽酶II可能会增加肾内和血浆激肽水平,并且激肽肽降解减少可能对抑肽酶的急性高血压作用有显著贡献。